Loading...

Registration deadline: January 11th

1.5 CEs

Psychedelic medicines present a potentially new approach to treating conditions such as major depression, PTSD, substance use disorders, and distress related to life-threatening illness. However, their checkered past and hyped future leave some feeling skeptical. This workshop, presented by a nursing professor of psychopharmacology and an experienced psychedelic assisted therapy researcher, attempts to bring dispassionate nuance to the subject, exploring the history, mechanisms of action, and evidence for these treatments that bring together medication and psychotherapy, examining the potential opportunities and challenges that come with this new way of approaching the clinical treatment of some of our most vexing conditions.

This is an interactive synchronous distance learning course via Zoom.

General Admission: $35* 
*Discounts on individual workshops in the PAT series are available to WashU students, faculty, staff, field instructors, and alumnae.

Series Admission: $150** | Save up to $25 by registering for all 5 Psychedelic-Assisted Therapy Speaker Series workshops!
**Must add all 5 workshops to your cart to view and apply the discount. Series discount extended to Jan 11th.

Return to our list of Workshops

Course Outline

Content Level: Beginner

Target AudiencesAll mental health professionals and public health professionals.

Agenda:

  • Psychedelic history - 15 mins
  • Drug mechanisms of action and existing data on efficacy and safety -30 mins
  • Potential challenges in delivering this therapy in the future - 30 mins
  • Review; Q & A - 15 mins

Learner Outcomes

  • Describe the historical evolution of psychedelic medicines, including key events that shaped public perception, regulation, and clinical use.
  • Explain the proposed mechanisms of action and therapeutic processes involved in psychedelic-assisted treatments for conditions such as major depression, PTSD, substance use disorders, and end-of-life distress.
  • Identify current evidence, opportunities, and challenges associated with integrating psychedelic medicines into modern clinical practice, including safety considerations and the role of psychotherapy.

Course Completion Requirements:

  • The Brown School, Washington University in St. Louis, Professional Development, provider #2130, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 9/24/2025 – 9/24/2028. Social workers completing this course receive 3 clinical continuing education credits.
  • The Brown School is also an approved provider of Social Work CEs in Missouri and Illinois.
  • To earn ACE credit, attendees must arrive at the scheduled time, attend the entire course, and complete an online course evaluation. ACE credit is not provided for partial attendance.  However, you may still qualify for partial Social Work Missouri and Illinois CEs provided by the Brown School.
  • Brown School CE Certificates will be available online within 10 business days of course completion by visiting your learner profile at https://ce.wustl.edu/portal/logon.do?method=load&parentSite=brown.  You will receive an email notification with specific instructions for accessing the online certificate when it is available. ACE CE Certificates, if requested in your evaluation survey, will be emailed within 10 business days of course completion.
  • For more information about CEs, accessibility, refund/cancellation policy, our grievance policy, or other inquiries, please visit our About Us page or email brownprofdev@wustl.edu.
Loading...
Thank you for your interest in this course. Unfortunately, the course you have selected is currently not open for enrollment. Please complete a Course Inquiry so that we may promptly notify you when enrollment opens.
Required fields are indicated by .